Knoll Capital Management, LLC Diversified Active

CIK: 0001325083 · Show all filings

Period: Q2 2023 (← Previous) (Next →)

Filing Date: Aug 15, 2023

Total Value ($000): $82,490 (100.0% shares, 0.0% debt)

Holdings (27)

ALDX Aldeyra Therapeutics Inc 30.7%
Value ($000) $25,301 Shares 3,015,668 Est. Cost $7.17 Unrealized +37.5%
Biohaven Pharmactl Hldg Co L 13.1%
Value ($000) $10,774 Shares 450,422 Est. Cost $32.04 Unrealized
Avadel Pharmaceuticals Plc 10.0%
Value ($000) $8,240 Shares 500,000 Est. Cost $16.48 Unrealized
HOOKIPA PHARMA 5.9%
Value ($000) $4,855 Shares 5,517,385 Est. Cost $0.87 Unrealized
Applied Therapeutics Inc 5.4%
Value ($000) $4,416 Shares 3,450,000 Est. Cost $5.66 Unrealized
Verona Pharma 5.1%
Value ($000) $4,228 Shares 200,000 Est. Cost $22.97 Unrealized
GDX Vaneck Gold Miners ETF 3.4%
Value ($000) $2,766 Shares 91,850 Est. Cost $28.66 Unrealized
SIL Global X Silver Miners ETF 37954Y848 2.8%
Value ($000) $2,331 Shares 89,700 Est. Cost $28.17 Unrealized
ENTX Entera Bio Ltd 2.5%
Value ($000) $2,094 Shares 2,484,275 Est. Cost $3.46 Unrealized -75.3%
GDXJ Vaneck Junior Gold Miners ETF 2.3%
Value ($000) $1,895 Shares 53,150 Est. Cost $35.65 Unrealized
BAH Booz Allen Hamilton HLDG COR 1.8%
Value ($000) $1,451 Shares 13,000 Est. Cost $76.36 Unrealized +22.6%
V Visa 1.4%
Value ($000) $1,152 Shares 4,850 Est. Cost $203.18 Unrealized +10.5%
TMO Thermo Fischer Scientific Inc 1.3%
Value ($000) $1,096 Shares 2,100 Est. Cost $471.13 Unrealized +13.6%
OCUL Ocular Therapeutix Inc. 1.3%
Value ($000) $1,032 Shares 200,000 Est. Cost $4.75 Unrealized +25.2%
MO Altria Group Inc 1.2%
Value ($000) $1,028 Shares 22,700 Est. Cost $30.41 Unrealized +20.2%
CVS CVS Health Corp 1.2%
Value ($000) $1,002 Shares 14,500 Est. Cost $62.28 Unrealized +3.2%
FNV Franco Nev Corp CAD 1.2%
Value ($000) $998 Shares 7,000 Est. Cost $135.73 Unrealized +7.9%
Silvercrest Metals Inc CAD 1.2%
Value ($000) $996 Shares 170,000 Est. Cost $6.14 Unrealized
NOC Northrop Grumman Corp 1.2%
Value ($000) $987 Shares 2,165 Est. Cost $442.02 Unrealized -1.9%
OSISKO GOLD ROYALTIES LTD 1.2%
Value ($000) $969 Shares 400,000 Est. Cost $2.88 Unrealized
Omega Therapeutics Inc. 1.2%
Value ($000) $969 Shares 173,010 Est. Cost $6.03 Unrealized
SA SEABRIDGE GOLD INC 1.2%
Value ($000) $964 Shares 80,000 Est. Cost $14.95 Unrealized -9.1%
Orgenesis, Inc. 1.1%
Value ($000) $882 Shares 634,738 Est. Cost $6.08 Unrealized
OCUL Ocular Therapeutix Inc. 1.0%
Value ($000) $814 Shares 95,800 Est. Cost $4.75 Unrealized +25.2%
ALT Altimmune Inc 0.7%
Value ($000) $614 Shares 173,864 Est. Cost $12.66 Unrealized -64.5%
IRD Ocuphire Pharma Inc. 0.5%
Value ($000) $434 Shares 100,000 Est. Cost $3.59 Unrealized +32.2%
BioXcell 0.2%
Value ($000) $200 Shares 30,000 Est. Cost $6.66 Unrealized